Reassessing the Diagnostic Value of Airway Biochemical Markers and Physical Tracers for Microaspiration and VAP in Critically Ill Mechanically Ventilated Patients: A Systematic Review and Meta-Analysis

Summarise with VIRAT
Authors: Suwen Li
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

This systematic review and dual diagnostic test accuracy (DTA) meta-analysis evaluates the diagnostic performance of bed-side tools for microaspiration and predictive value of airway biomarkers for aspiration-related ventilator-associated pneumonia (VAP) in mechanically ventilated adults. Microaspiration is the core pathogenic driver of VAP, yet the clinical positioning of the most widely used bedside microaspiration screening tool (modified blue dye test, MBDT) remains highly controversial, and the diagnostic accuracy of promising biomarkers such as airway α-amylase lacks unified, high-quality evidence-based verification. These gaps are largely driven by widespread heterogeneity in study designs, reference standard selection, and population definitions across existing literature. To address these critical methodological limitations, this study adopts a two-tiered, prospectively defined stratified synthesis strategy: Quantitative Synthesis (Dual Independent DTA Meta-Analysis): Separate meta-analyses will be performed for the two core clinical questions with sufficient homogeneous data: Primary Meta-Analysis 1: Diagnostic accuracy of MBDT for detecting microaspiration, with inclusion strictly restricted to studies using an objective microaspiration reference standard (fiberoptic endoscopic evaluation of swallowing [FEES], video fluoroscopic swallowing study [VFSS], or quantitative airway pepsin/fluorescent microsphere testing) to avoid incorporation bias. Primary Meta-Analysis 2: Predictive accuracy of lower respiratory tract α-amylase for incident VAP, with inclusion strictly restricted to studies using a validated clinical VAP reference standard (ATS/IDSA guideline definition, CPIS/mCPIS with quantitative microbiological culture, or CDC/NHSN criteria) to ensure prognostic and clinical validity. Pre-specified subgroup analyses will be conducted for both meta-analyses to investigate drivers of heterogeneity, including specimen matrix, test protocol characteristics, reference standard type, and clinical course of mechanical ventilation. Qualitative Synthesis (Dual-Module Systematic Review): A systematic review of cohort studies will be performed to quantify the impact of microaspiration on hard clinical outcomes (VAP incidence, all-cause mortality, ICU length of stay) in mechanically ventilated adults. A comprehensive narrative synthesis will be conducted for other microaspiration-related biomarkers (e.g., pepsin, bile acids, lipid-laden macrophages) with insufficient or heterogeneous data for quantitative pooling. These studies will be critically appraised for biological plausibility and methodological quality, with a focus on identifying gaps in current evidence. This review aims to provide an updated, rigorously stratified evidence-based assessment of microaspiration screening tools and VAP predictive biomarkers, and to deliver clear, actionable clinical practice recommendations for the early prevention and control of VAP in the intensive care unit (ICU).

Fields of Study & Subjects

Nosocomial Infections in ICU Dysphagia Assessment and Management Airway Management and Intubation Techniques

Publication details

Journal / source
OSF Preprints (OSF Preprints)
Publication date
21 March 2026
Language
EN
Document type
Preprint